Primary biliary cirrhosis (PBC) is a classical autoimmune liver disease for which effective immunomodulatory therapy is lacking. Here we perform meta-analyses of discovery data sets from genome-wide association studies of European subjects (n=2,764 cases and 10,475 controls) followed by validation genotyping in an independent cohort (n=3,716 cases and 4,261 controls). We discover and validate six previously unknown risk loci for PBC (Pcombined<5 × 10(-8)) and used pathway analysis to identify JAK-STAT/IL12/IL27 signalling and cytokine-cytokine pathways, for which relevant therapies exist.
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways / Heather J., C., Younghun, H., George F., M., Yafang, L.i., Gideon M., H., Casey S., G., Gang, X., Brian D., J., Dakai, Z., David C., Q., James A. B., F., Katherine I., M., Daniele, P., Ana, L., Daniele, C., Canadian US PBC, C., Italian PBC Genetics Study, G., UK PBC, C., M., E.G., Carl A., A., et al.. - In: NATURE COMMUNICATIONS. - ISSN 2041-1723. - ELETTRONICO. - 6(2015):Sept(2015), pp. 8019.1-8019.11. [10.1038/ncomms9019]
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways
TIRIBELLI, CLAUDIO
2015-01-01
Abstract
Primary biliary cirrhosis (PBC) is a classical autoimmune liver disease for which effective immunomodulatory therapy is lacking. Here we perform meta-analyses of discovery data sets from genome-wide association studies of European subjects (n=2,764 cases and 10,475 controls) followed by validation genotyping in an independent cohort (n=3,716 cases and 4,261 controls). We discover and validate six previously unknown risk loci for PBC (Pcombined<5 × 10(-8)) and used pathway analysis to identify JAK-STAT/IL12/IL27 signalling and cytokine-cytokine pathways, for which relevant therapies exist.| File | Dimensione | Formato | |
|---|---|---|---|
|
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways.pdf
accesso aperto
Descrizione: pdf editoriale
Tipologia:
Documento in Versione Editoriale
Licenza:
Digital Rights Management non definito
Dimensione
300.9 kB
Formato
Adobe PDF
|
300.9 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


